Philip W. Gold
#101,018
Most Influential Person Now
Philip W. Gold's AcademicInfluence.com Rankings
Philip W. Goldbiology Degrees
Biology
#5049
World Rank
#7436
Historical Rank
Neuroscience
#559
World Rank
#582
Historical Rank
Download Badge
Psychology Biology
Why Is Philip W. Gold Influential?
(Suggest an Edit or Addition)Philip W. Gold's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. (1992) (3846)
- Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states (2002) (1278)
- Mood Disorders in the Medically Ill: Scientific Review and Recommendations (2005) (1009)
- Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) (1988) (925)
- Mechanisms of stress: A dynamic overview of hormonal and behavioral homeostasis (1992) (847)
- Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. (1989) (740)
- Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. (1991) (738)
- Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. (1990) (689)
- Human leptin levels are pulsatile and inversely related to pituitary–ardenal function (1997) (670)
- Interactions between the Hypothalamic-Pituitary-Adrenal Axis and the Female Reproductive System: Clinical Implications (1998) (657)
- A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. (1989) (579)
- Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. (2000) (551)
- Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. (1994) (531)
- Neuroendocrinology of stress. (2001) (518)
- The organization of the stress system and its dysregulation in depressive illness (2014) (463)
- Bone mineral density in women with depression. (1996) (457)
- Circadian interleukin-6 secretion and quantity and depth of sleep. (1999) (449)
- The stress response and the regulation of inflammatory disease. (1992) (448)
- INDUCTION OF CORTICOTROPIN-RELEASING HORMONE GENE EXPRESSION BY GLUCOCORTICOIDS: IMPLICATION FOR UNDERSTANDING THE STATES OF FEAR AND ANXIETY AND ALLOSTATIC LOAD (1998) (439)
- Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. (1998) (424)
- Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. (1986) (411)
- Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. (2000) (390)
- Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels. (1995) (381)
- Suppression of hypothalmic-pituitary-adrenal axis responses to stress in lactating women. (1995) (373)
- Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. (2005) (362)
- Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. (1991) (341)
- A healthy body in a healthy mind--and vice versa--the damaging power of "uncontrollable" stress. (1998) (330)
- Allostasis, amygdala, and anticipatory angst (1994) (326)
- The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. (1984) (318)
- Behavioral and neuroendocrine responses in shy children. (1997) (310)
- Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. (1998) (307)
- Alterations in immunocompetence during stress, bereavement, and depression: focus on neuroendocrine regulation. (1987) (296)
- Food selection and intake of obese women with binge-eating disorder. (1992) (291)
- The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. (1999) (287)
- Inducible nitric oxide synthase gene expression in the brain during systemic inflammation (1996) (283)
- Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. (1993) (273)
- Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats (1992) (266)
- Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. (1997) (256)
- Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress (2002) (252)
- Sleep deprivation effects on the activity of the hypothalamic–pituitary–adrenal and growth axes: potential clinical implications (1999) (251)
- The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications (1992) (245)
- Exercise and Circadian Rhythm-Induced Variations in Plasma Cortisol Differentially Regulate Interleukin-1β (IL-1β), IL-6, and Tumor Necrosis Factor-α (TNFα) Production in Humans: High Sensitivity of TNFα and Resistance of IL-6 (1997) (241)
- Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. (1990) (240)
- The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. (1999) (239)
- Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. (1996) (239)
- The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. (1997) (237)
- Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. (1996) (234)
- Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami (1989) (226)
- New insights into the role of cortisol and the glucocorticoid receptor in severe depression (2002) (219)
- Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress. (1995) (219)
- Corticotropin Releasing Hormone in the Pathophysiology of Melancholic and Atypical Depression and in the Mechanism of Action of Antidepressant Drugs (1995) (212)
- Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. (2001) (209)
- Behavioral and psychophysiological correlates of self-presentation in temperamentally shy children. (1999) (203)
- Sex differences in circulating human leptin pulse amplitude: clinical implications. (1998) (199)
- Differential hypothalamic-pituitary-adrenal axis reactivity to psychological and physical stress. (1999) (199)
- Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. (1984) (198)
- Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1) (1988) (193)
- Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. (1994) (184)
- Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro. (1988) (181)
- Relation of clinical variables to dissociative phenomena in eating disorders. (1990) (173)
- Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro (1988) (172)
- Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. (1990) (171)
- Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. (2003) (170)
- Induction of c-fos mRNA in rat brain by conditioned and unconditioned stressors (1992) (167)
- Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat (1999) (166)
- Depression: a major, unrecognized risk factor for osteoporosis? (2001) (164)
- Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. (2000) (163)
- Low bone mass in premenopausal women with depression. (2007) (161)
- A prospective study of the association among impaired executive functioning, childhood attentional problems, and the development of bipolar disorder (2004) (153)
- Long-term outcomes of youth who manifested the CBCL-Pediatric Bipolar Disorder phenotype during childhood and/or adolescence. (2009) (152)
- CRF-induced seizures and behavior: Interaction with amygdala kindling (1986) (151)
- Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. (1991) (149)
- Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications. (1988) (149)
- VASOPRESSIN IN AFFECTIVE ILLNESS (1978) (148)
- The hypothalamic-pituitary-adrenal axis in anorexia nervosa (1996) (144)
- Psychopathology in patients with endogenous Cushing's syndrome: ‘atypical’ or melancholic features (1995) (143)
- Endogenous interleukin-1 receptor antagonist is neuroprotective. (1997) (142)
- Repeated Immobilization Stress Alters Tyrosine Hydroxylase, Corticotropin‐Releasing Hormone and Corticosteroid Receptor Messenger Ribonucleic Acid Levels in Rat Brain (1992) (134)
- Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications. (1991) (133)
- The biobehavioral consequences of psychogenic stress in a small, social primate (Callithrix jacchus jacchus) (1996) (127)
- Effects of stress and adrenalectomy on tyrosine hydroxylase mRNA levels in the locus ceruleus by in situ hybridization (1991) (126)
- Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. (1997) (117)
- Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications. (2002) (116)
- Major depression and the stress system: A life span perspective (2001) (116)
- Hormonal and metabolic responses to exercise across time of day and menstrual cycle phase. (1997) (115)
- CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations. (1990) (114)
- In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications. (1990) (114)
- Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. (1992) (112)
- Clinical Applications of Corticotropin-Releasing Factor (1985) (111)
- Mechanisms of Physical and Emotional Stress (1988) (111)
- Clinical studies with corticotropin releasing factor: implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiency (1985) (110)
- Localization of interleukin-1 receptor antagonist mRNA in rat brain. (1991) (110)
- Individual reactivity and physiology of the stress response. (2000) (109)
- Changes in corticosteroid sensitivity of peripheral blood lymphocytes after strenuous exercise in humans. (1996) (107)
- The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency. (1984) (107)
- Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls (2001) (104)
- The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundancies of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat (1994) (104)
- Sustained Low-Grade Pro-inflammatory State in Unmedicated, Remitted Women with Major Depressive Disorder as Evidenced by Elevated Serum Levels of the Acute Phase Proteins C-reactive Protein and Serum Amyloid A (2007) (104)
- Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications. (1985) (103)
- Stress and reproduction: physiologic and pathophysiologic interactions between the stress and reproductive axes. (1988) (103)
- Corticosterone Potentiation of Conditioned Fear in Rats a (1994) (102)
- Pathological parainflammation and endoplasmic reticulum stress in depression: potential translational targets through the CNS insulin, klotho and PPAR-γ systems (2013) (101)
- Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. (2005) (99)
- Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers. (1987) (97)
- Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro. (1988) (97)
- L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat. (1990) (95)
- Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome. (1990) (94)
- Corticotropin-releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin peptides. (1988) (93)
- PLASMA MELATONIN IN MANIC-DEPRESSIVE ILLNESS (1979) (92)
- Relationship of cortisol hypersecretion to brain CT scan alterations in depressed patients (1983) (92)
- Pituitary and adrenal responses to the anti-progesterone and anti-glucocorticoid steroid RU 486 in primates. (1983) (92)
- Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone. (1992) (91)
- Male Fischer 344/N rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing age. (1994) (90)
- Increased adrenocorticotropin, cortisol, and arginine vasopressin secretion in primates after the antiglucocorticoid steroid RU 486: dose response relationships. (1985) (90)
- Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry. (1994) (89)
- Cocaine stimulates rat hypothalamic corticotropin-releasing hormone secretion in vitro (1989) (88)
- Altered expression of type 2 CRH receptor mRNA in the VMH by glucocorticoids and starvation. (1998) (88)
- Localization of urocortin messenger RNA in rat brain and pituitary. (1996) (87)
- Arachidonic acid metabolites modulate rat hypothalamic corticotropin-releasing hormone secretion in vitro. (1989) (87)
- Hippocampal 8‐[3H]Hydroxy‐2‐(Di‐n‐Propylamino)Tetralin Binding Site Densities, Serotonin Receptor (5‐HT1A) Messenger Ribonucleic Acid Abundance, and Serotonin Levels Parallel the Activity of the Hypothalamopituitary‐Adrenal Axis in Rat (1992) (85)
- EFFECTS OF 1-DESAMO-8-D-ARGININE VASOPRESSIN ON BEHAVIOUR AND COGNITION IN PRIMARY AFFECTIVE DISORDER (1979) (84)
- Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats. (1991) (84)
- Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and ‘well-state’ bipolar patients (1982) (84)
- Eating behavior in bulimia nervosa: multiple meal analyses. (1994) (82)
- The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. (1989) (81)
- Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients. (1981) (81)
- Clinical Subtypes of Depression Are Associated with Specific Metabolic Parameters and Circadian Endocrine Profiles in Women: The Power Study (2012) (81)
- Stress system abnormalities in melancholic and atypical depression: molecular, pathophysiological, and therapeutic implications. (1996) (80)
- Neurobiological characteristics of rhesus macaque abusive mothers and their relation to social and maternal behavior (2005) (80)
- The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man. (1987) (79)
- Regulatory role of glucocorticoids and glucocorticoid receptor mRNA levels on tyrosine hydroxylase gene expression in the locus coeruleus during repeated immobilization stress (2002) (79)
- Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. (1986) (79)
- Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans. (1997) (78)
- Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation. (2002) (78)
- Cerebrospinal fluid concentrations of corticotropin‐releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease (1987) (78)
- Normal CSF oxytocin and NPY levels in OCD (1999) (77)
- Plasma leptin levels do not change in patients with Cushing's disease shortly after correction of hypercortisolism. (1997) (76)
- The effects of corticotropin releasing factor on the anterior pituitary function of stalk-sectioned cynomolgus macaques: dose response of cortisol secretion. (1982) (75)
- Corticotropin-releasing factor: pharmacokinetics in man. (1984) (75)
- The stress response in critical illness. (1994) (74)
- Marked differences in functioning of the hypothalamic-pituitary-adrenal axis between groups of men. (1997) (74)
- Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: Preliminary findings (1992) (73)
- Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs (2002) (71)
- The oCRH stimulation test before and after clinical recovery from depression. (1988) (70)
- Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion. (1996) (70)
- Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk. (2005) (69)
- The role of adipokines in the rapid antidepressant effects of ketamine (2017) (69)
- Experimentally-induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis. (2005) (66)
- Ovine corticotropin-releasing factor administration in normal men. Pituitary and adrenal responses in the morning and evening. (1985) (65)
- Pituitary-adrenal axis responsiveness to ovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low dose prednisone. (1992) (65)
- Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal cortisol secretory pattern. (1986) (64)
- Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression. (2017) (63)
- Low- versus High-Baseline Epinephrine Output Shapes Opposite Innate Cytokine Profiles: Presence of Lewis- and Fischer-Like Neurohormonal Immune Phenotypes in Humans? (2008) (62)
- Corticotropin-releasing factor: a marked circadian rhythm in primate cerebrospinal fluid peaks in the evening and is inversely related to the cortisol circadian rhythm. (1987) (58)
- The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness (1989) (56)
- High intensity exercise promotes escape of adrenocorticotropin and cortisol from suppression by dexamethasone: sexually dimorphic responses. (1998) (56)
- Response to oCRH in depressed and nondepressed adolescents: does gender make a difference? (1996) (55)
- Focal cerebral ischemia induces CRH mRNA in rat cerebral cortex and amygdala (1995) (55)
- Stress : basic mechanisms and clinical implications (1995) (55)
- Supression of plasma cortisol in depressed patients by acute intravenous methadone infusion. (1980) (54)
- Chronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro (1992) (54)
- Autoimmune thyroiditis in manic-depressive patients treated with lithium. (1985) (53)
- Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress. (1999) (52)
- Differences in corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol before and after weight loss. (1997) (52)
- Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: Changes in panic disorder and effects of alprazolam treatment (1997) (52)
- Effects of electroconvulsive therapy on the CRH-ACTH-cortisol system in melancholic depression: preliminary findings. (1994) (51)
- Melancholic and atypical subtypes of depression represent distinct pathophysiological entities: CRH, neural circuits, and the diathesis for anxiety and depression (2013) (51)
- Effects of peripheral benzodiazepine receptor ligands on hypothalamic-pituitary-adrenal axis function in the rat. (1990) (50)
- Neuroendocrinology of stress: implications for growth and development. (1995) (50)
- Glucocorticoid receptor gene polymorphisms in premenopausal women with major depression. (2008) (49)
- Rapid eye movement sleep correlates with the overall activities of the hypothalamic-pituitary-adrenal axis and sympathetic system in healthy humans. (1997) (49)
- Social withdrawal behaviors in nonhuman primates and changes in neuroendocrine and monoamine concentrations during a separation paradigm. (2005) (48)
- Cerebrospinal fluid corticotropin-releasing hormone in depression: Relationship to noradrenergic function (1987) (48)
- Age and gender influence basal and stress-modulated hypothalamic-pituitary-thyroidal function in Fischer 344/N rats. (1996) (48)
- Stress hormone responses to corticotropin-releasing hormone in substance abusers without severe comorbid psychiatric disease (2003) (47)
- A Defect in the Central Component of the Immune System‐ Hypothalamic‐Pituitary‐Adrenal Axis Feedback Loop Is Associated with Susceptibility to Experimental Arthritis and Other Inflammatory Diseases (1990) (46)
- Aging Is Associated in the 344/N Fischer Rat with Decreased Stress Responsivity of Central and Peripheral Catecholaminergic Systems and Impairment of the Hypothalamic‐Pituitary‐Adrenal Axis (1995) (46)
- Diurnal variation of cerebrospinal fluid immunoreactive corticotropin-releasing hormone levels in healthy volunteers. (1994) (46)
- Abnormal acth and cortisol responses to ovine corticotropin releasing factor in patients with primary affective disorder (1986) (45)
- Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1β and αMSH: studies in rats with different susceptibility to inflammatory disease (1993) (45)
- Adrenocortical reactivity and social competence in seven year-olds (1999) (43)
- Hormonal responses to the stress of exercise. (1988) (43)
- Acute Ketamine Administration Corrects Abnormal Inflammatory Bone Markers in Major Depressive Disorder (2017) (43)
- Glucocorticoid-Induced Osteoporosis: From Basic Mechanisms to Clinical Aspects (2005) (43)
- Effects of Early Parenting on Growth and Development in a Small Primate (1996) (42)
- The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary-adrenal axis in the rat. (1989) (42)
- Differential behavioral response in LEW/N and F344/N rats: Effects of corticotropin releasing hormone (1992) (41)
- A prospective high-risk study of the association among maternal negativity, apparent frontal lobe dysfunction, and the development of bipolar disorder (2006) (41)
- Localization of Interleukin-1βP Converting Enzyme mRNA in Rat Brain Vasculature: Evidence that the Genes Encoding the Interleukin-1 System Are Constitutively Expressed in Brain Blood Vessels (1995) (41)
- Potential Uses of Corticotropin‐Releasing Hormone Antagonists (2006) (41)
- Regulation of appetite and cholecystokinin secretion in anorexia nervosa. (1992) (41)
- Regulation of rat hypothalamic corticotropin-releasing hormone secretion in vitro: potential clinical implications. (1988) (41)
- Effects of the glucocorticoid antagonist RU 486 on pituitary-adrenal function in patients with anorexia nervosa and healthy volunteers: enhancement of plasma ACTH and cortisol secretion in underweight patients. (1993) (40)
- Stress-responsive neurohormonal systems and the symptom complex of affective illness. (1989) (40)
- High reverse T3 levels in manic and unipolar depressed women (1982) (38)
- GROWTH-HORMONE AND PROLACTIN RESPONSE TO LEVODOPA IN AFFECTIVE ILLNESS (1976) (38)
- The Kynurenine Pathway and Bipolar Disorder: Intersection of the Monoaminergic and Glutamatergic Systems and Immune Response (2019) (38)
- Neuroimmunomodulation: Molecular Aspects, Integrative Systems, and Clinical Advances. Proceedings of the 3rd Congress of the International Society of NeuroImmunoModulation (ISNIM). Bethesda, Maryland, USA. November 13-15 , 1996. (1998) (38)
- Metabolic clearance rate and plasma half-life of radioiodinated corticotropin releasing factor in a primate. (1982) (37)
- Abnormalities in response to vasopressin infusion in chronic fatigue syndrome (2001) (37)
- A Major Role for the Lateral Habenula in Depressive Illness: Physiologic and Molecular Mechanisms (2019) (37)
- Facilitation of cocaine kindling by glucocorticoids in rats (1993) (36)
- Differences in the hypothalamic-pituitary-adrenal axis of black and white women. (1993) (36)
- Pre- and post-dexamethasone plasma ACTH levels in depressed patients and normal controls. (1986) (36)
- Central hypothyroidism is associated with advanced age in male Fischer 344/N rats: in vivo and in vitro studies. (1992) (36)
- Corticotropin-releasing hormone: from endocrinology to psychobiology. (1989) (36)
- Neuroendocrine responses to apomorphine in depressed patients and healthy control subjects (1984) (36)
- Endocrinologic and psychologic evaluation of 21-hydroxylase deficiency carriers and matched normal subjects: evidence for physical and/or psychologic vulnerability to stress. (2004) (35)
- A molecular mechanism for stress-induced alterations in susceptibility to disease (1995) (35)
- Arthritis-susceptible Lewis rats fail to emerge from the stress hyporesponsive period. (1992) (35)
- Simultaneous and continuous 24-hour plasma and cerebrospinal fluid leptin measurements: dissociation of concentrations in central and peripheral compartments. (2004) (35)
- β-Endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action (1990) (34)
- Effects of amygdala kindling and electroconvulsive seizures on the expression of corticotropin-releasing hormone in the rat brain (1991) (34)
- Differential mineralocorticoid (type 1) and glucocorticoid (type 2) receptor expression in Lewis and Fischer rats. (1994) (34)
- Differential effects of kindled and electrically induced seizures on a glutamate receptor (GluR1) gene expression (1993) (34)
- “Environmental stress” and reproductive success in the common marmoset (Callithrix jacchus jacchus) (1991) (33)
- Role of CRH in Glucopenia‐lnduced Adrenomedullary Activation in Rats (1993) (33)
- Behavioral, adrenal, and sympathetic responses to long-term administration of an oral corticotropin-releasing hormone receptor antagonist in a primate stress paradigm. (2004) (33)
- The Mind-Body Interaction in Disease (2008) (32)
- Lithium Decreases Plasma Adiponectin Levels in Bipolar Depression (2014) (32)
- Autoradiographic visualization of corticotropin releasing hormone type 1 receptors with a nonpeptide ligand: synthesis of [(76)Br]MJL-1-109-2. (2003) (32)
- CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists. (2002) (32)
- Active clearance of corticotropin-releasing factor from the cerebrospinal fluid. (1985) (32)
- Lymphocyte subset responses to exercise and glucocorticoid suppression in healthy men. (1996) (31)
- Thyroid hormone concentrations in depressed and nondepressed adolescents: group differences and behavioral relations. (1996) (31)
- Neuropeptides in human cerebrospinal fluid. (1985) (31)
- Differential gene expression profile of glucocorticoids, testosterone, and dehydroepiandrosterone in human cells. (2001) (31)
- Glucocorticoid treatment increases the ability of CRH to induce seizures (1994) (31)
- Effects and pharmacokinetic properties of the rat/human corticotropin-releasing factor in rhesus monkeys. (1985) (30)
- CSF somatostatin in anorexia nervosa and bulimia: Relationship to the hypothalamic pituitary-adrenal cortical axis (1988) (30)
- Dissociation between cortisol and adrenal androgen secretion in patients receiving alternate day prednisone therapy. (1987) (30)
- Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: Relation to clinical and biochemical variable (1995) (30)
- Continuity and cascade in offspring of bipolar parents: A longitudinal study of externalizing, internalizing, and thought problems (2010) (30)
- CSF Neuropeptides in Euthymic Bipolar Patients and Controls (1987) (30)
- Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and beta-endorphin in patients with eating disorders: A pilot study (1993) (30)
- Stress-induced inhibition of the hypothalamic-pituitary-thyroid axis is attenuated in the aged Fischer 344/N male rat. (1995) (30)
- In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat. (1994) (29)
- Hypothalamic-pituitary-adrenal axis and monoamine transmitter activity in depression: A pilot study of central and peripheral effects of electroconvulsive therapy (1991) (29)
- Induction of constitutive heat shock protein 73 mRNA in the dentate gyrus by seizures. (1992) (29)
- Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion. (1993) (29)
- Normal dexamethasone suppression in obese binge and nonbinge eaters with rapid weight loss. (1993) (28)
- Neutrophil-activating peptide-1/interleukin-8 mRNA is localized in rat hypothalamus and hippocampus. (1992) (28)
- Thyroid function in bulimia nervosa (1996) (27)
- Introduction: The Concept of Stress and Its Historical Development (1988) (27)
- The effects of carbamazepine on the thyrotropin response to thyrotropin-releasing hormone (1984) (27)
- Increased hypothalamic [3H]flunitrazepam binding in hypothalamic-pituitary-adrenal axis hyporesponsive Lewis rats (1992) (27)
- In vitro regulation of pituitary ACTH secretion in inflammatory disease susceptible Lewis (LEW/N) and inflammatory disease resistant Fischer (F344/N) rats. (1992) (27)
- Hippocampal 5-HT1A receptor binding site densities, 5-HT1A receptor messenger ribonucleic acid abundance and serotonin levels parallel the activity of the hypothalamo-pituitary-adrenal axis in rats (1995) (26)
- Oxytocin: Neurobiologic considerations and their implications for affective illness (1988) (26)
- Meal-related cholecystokinin secretion in eating and affective disorders. (1989) (26)
- Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH (1990) (25)
- Hormonal responses to zimelidine and desipramine in depressed patients (1984) (25)
- Do Premenopausal Women with Major Depression Have Low Bone Mineral Density? A 36-Month Prospective Study (2012) (25)
- Depression and osteoporosis in men: association or casual link? (2006) (25)
- Tricyclic antidepressants do not alter thyroid hormone levels in patients suffering from a major affective disorder (1981) (24)
- Biochemical effects of carbamazepine: Relationship to its mechanisms of action in affective illness (1983) (24)
- Relationship between urinary free cortisol and CSF opioid binding activity in depressed patients and normal volunteers (1981) (23)
- Identification, characterization, and gene expression profiling of endotoxin-induced myocarditis (2003) (23)
- Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: the development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor. (2000) (23)
- Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH. (1986) (23)
- Corticotropin releasing factor: basic and clinical studies. (1983) (23)
- Cytokines in the Brain (1996) (22)
- Immobilization stress rapidly decreases hypothalamic corticotropin-releasing hormone secretion in vitro in the male 344/N Fischer rat. (1993) (22)
- L-Carnitine and acetyl-L-carnitine in the treatment of complications associated with HIV infection and antiretroviral therapy. (2004) (22)
- The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia (2014) (22)
- Activity-induced anorexia in rats does not affect hypothalamic neuropeptide gene expression chronically. (1993) (22)
- Corticotropin releasing factor: Basic studies and clinical applications (1985) (22)
- The hypothalamic-pituitary-adrenal axis in anorexia nervosa and bulimia nervosa: pathophysiologic implications. (1991) (22)
- Pharmacology of ovine and human CRH. (1987) (21)
- Neuroendocrine effects of limbic activation by electrical, spontaneous, and pharmacological modes: Relevance to the pathophysiology of affective dysregulation in psychiatric disorders (1987) (21)
- Pathophysiologic and Somatic Investigations of Hypothalamic‐Pituitary‐Adrenal Axis Activation in Patients with Depression (1998) (21)
- Pro-opiomelanocortin-related peptides in cerebrospinal fluid: A study of manic-depressive disorder (1985) (21)
- Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression (2017) (21)
- Stress-responsive neuromodulators (1988) (21)
- Characteristics of cerebrospinal fluid neuropeptides relevant to clinical research (1988) (21)
- Decrease in resting metabolic rate during abstinence from bulimic behavior. (1991) (21)
- Eating pathology in bulimia nervosa. (1993) (20)
- Identification of hypothalamic transcripts upregulated by antidepressants. (1996) (20)
- Lymphocyte subpopulation expression in women: effect of exercise and circadian rhythm. (1997) (20)
- Unmedicated, remitted patients with major depression have decreased serum immunoglobulin A (2012) (19)
- The NMR-MOUSE: quality control of elastomers. (2001) (19)
- The human mineralocorticoid receptor gene promoter: Its structure and expression (1996) (19)
- Distribution of hippocampal mineralocorticoid and glucocorticoid receptor mRNA in a glucocorticoid resistant nonhuman primate (1996) (19)
- The estrogen antagonist tamoxifen inhibits carrageenan induced inflammation in LEW/N female rats. (1996) (19)
- Localization of interleukin-1 beta converting enzyme mRNA in rat brain vasculature: evidence that the genes encoding the interleukin-1 system are constitutively expressed in brain blood vessels. Pathophysiological implications. (1995) (18)
- Neurotransmitter Metabolism in Anorexia Nervosa (1984) (17)
- Naloxone-Induced Pituitary-Adrenal Activation Does Not Differ in Patients with Depression, Obsessive Compulsive Disorder, and Healthy Controls (1996) (17)
- The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type. (2001) (17)
- Imipramine reduces the local inflammatory response to carrageenin (1994) (17)
- Effects of glucocorticoid antagonism with RU 486 on pituitary-adrenal function in patients with major depression: time-dependent enhancement of plasma ACTH secretion. (1989) (17)
- SAFETY OF CORTICOTROPIN-RELEASING FACTOR (1983) (16)
- Development of a human mitochondria-focused cDNA microarray (hMitChip) and validation in skeletal muscle cells: implications for pharmaco- and mitogenomics (2006) (16)
- Type I glucocorticoid receptor blockade does not affect baseline or ovine corticotropin-releasing-hormone-stimulated adrenocorticotropic hormone and cortisol secretion. (1994) (16)
- The neurobiology of stress and its relevance to psychotherapy (2005) (16)
- Preface: Carnitine: Lessons from One Hundred Years of Research (2004) (15)
- Plasma levels of corticotropin-releasing hormone in the inferior petrosal sinuses of healthy volunteers, patients with Cushing's syndrome, and patients with pseudo-Cushing states. (1998) (15)
- Rapid mood cycling and concomitant cortisol changes produced by cyproheptadine. (1980) (15)
- Hypothalamic–Pituitary–Adrenal Axis (2020) (15)
- Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implications (2015) (14)
- Manic-depressive illness: psychodynamic features of multigenerational families. (1979) (14)
- The estrous cycle and pituitary-ovarian function in Lewis and Fischer rats. (1994) (14)
- NIH conference. Clinical applications of corticotropin-releasing factor. (1985) (13)
- High-dose transdermal estrogen, corticotropin-releasing hormone, and postnatal depression. (1997) (13)
- Thyroid function in Bulimia nervosa (1993) (13)
- Neuroendocrinology and psychiatric illness (1990) (13)
- [76Br]BMK‐I‐152, a non‐peptide analogue for PET imaging of corticotropin‐releasing hormone type 1 receptor (CRHR1) (2009) (12)
- Cerebrospinal Fluid as Neuroregulatory Pathway Peptides in Neuropsychiatric Illness (1983) (12)
- CSF somatostatin in affective illness and normal volunteers (1985) (12)
- The hypothalamic-pituitary-adrenal (HPA) axis: A major mediator of the adaptive responses to stress (2003) (12)
- Elevation of human plasma and platelet amine oxidase activity in response to intravenous dopamine. (1981) (12)
- 3-O-Formyl-20R,21-epoxyresibufogenin suppresses IL-6-type cytokine actions by targeting the glycoprotein 130 subunit: potential clinical implications. (2007) (12)
- Cortisol, thyroid hormone, and mood in atypical depression: A longitudinal case study (1992) (11)
- TETRAHYDROBIOPTERIN LEVELS IN CEREBROSPINAL FLUID OF AFFECTIVELY ILL PATIENTS (1983) (11)
- Role of corticotrophin releasing hormone 41 in depressive illness. (1991) (11)
- Neuroactive Substances in Cerebrospinal Fluid (1988) (11)
- Synthesis of [3H](4-fluorobutyl)propyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amine: a potent radioligand for corticotropin-releasing hormone type 1 receptor (2000) (11)
- Endocrine Factors in Key Structural and Intracellular Changes in Depression (2021) (11)
- Interparental violence and maternal mood disorders as predictors of adolescent physical aggression within the family. (2014) (11)
- Prednisone-induced behavioral and biological changes in medically healthy volunteers. (1988) (11)
- Neurohypophyseal dysfunction: implications for the pathophysiology of eating disorders. (1989) (10)
- Circulating cortisol‐associated signature of glucocorticoid‐related gene expression in subcutaneous fat of obese subjects (2013) (10)
- Pulsatility of 24-hour concentrations of circulating interleukin-1-alpha in healthy women: analysis of integrated basal levels, discrete pulse properties, and correlation with simultaneous interleukin-2 concentrations. (1994) (10)
- The PPARg System in Major Depression: Pathophysiologic and Therapeutic Implications (2021) (10)
- The development of thought problems: A longitudinal family risk study of offspring of bipolar, unipolar, and well parents (2013) (10)
- Neuroactive substances in cerebrospinal fluid. Normal and pathological regulatory mechanisms. (1988) (9)
- The gene encoding for the novel transacting factor proopiomelanocortin corticotropin-releasing hormone responsive element binding protein 1 (PCRH-REB-1) is constitutively expressed in rat pituitary and in discrete brain regions containing CRH or CRH receptors: pathophysiological implications. (1995) (9)
- Hypothalamic-pituitary-adrenal axis in panic disorder (1990) (9)
- Corticotropin-releasing factor stimulation test. (2010) (8)
- Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonist. (2008) (8)
- Aging and acute stress decrease corticotropin releasing hormone in the ovary of the Fischer 344/N rat. (1995) (8)
- Commentary on Part II The Inhibited Child “Syndrome”: Thoughts on Its Potential Pathogenesis and Sequelae (1999) (7)
- Antithyroid antibody-linked symptoms in borderline personality disorder (2003) (7)
- The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress* *This research was supported by NIMH Grant MH-50479 and the Undergraduate Research Opportunities Program at the University of Colorado at Boulder. (1999) (7)
- Report from the International Society of Endocrinology (1985) (6)
- Endorphins and Affective Illness (1982) (6)
- ‘Peripheral’ Benzodiazepine Receptor Ligands Stimulate Prolactin Release in the Rat (1990) (6)
- Effect of carbamazepine on mean urinary free cortisol excretion in patients with major affective illness (2004) (6)
- Effects of carbamazepine on cerebrospinal fluid somatostatin (1985) (6)
- Activation of blood coagulation in patients with major depressive disorder during euglycemic hyperinsulinemia. (2007) (6)
- CHAPTER 9 – Neurohormones in Depression and Anxiety (1993) (6)
- Effects of 24-h continuous oCRH infusion on ACTH and cortisol secretion patterns in man (1989) (5)
- Re-assessing the catecholamine hypothesis of depression: the case of melancholic depression (2021) (5)
- Intracerebroventricularly transplanted embryonic neuronal tissue from inflammatory-resistant F344/N rats decreases acoustic startle responses in inflammatory-susceptible LEW/N rats. (1996) (5)
- Interparental violence and maternal mood disorders as predictors of adolescent physical aggression within the family. (2014) (5)
- Central Peptide Function in Affective Illness: Arginine Vasopressin as a Model System (1981) (4)
- Cerebrospinal fluid amines and peptides in affective illness (1981) (3)
- Lack of Attention from Loss of Time (1998) (3)
- CSF prostaglandin-E in agoraphobia with panic attacks (1989) (3)
- Intramuscular administration of ACTH1-24 vs. 24-hour blood sampling in the assessment of adrenocortical function. (2005) (3)
- Evidence that stress per se has a role in the precipitation and natural history of depressive illness (2013) (3)
- Procaine and lidocaine stimulate corticotropin-releasing hormone secretion by explanted rat hypothalami through a sodium conductance-independent mechanism. (1990) (3)
- In Situ Hybridization Techniques for Localization of Interleukin 1 and Interleukin 1 Receptor Antagonist mRNA in Brain (1993) (2)
- Increased ACTH and cortisol secretion after interleukin-alpha injection in the common marmoset (Callithrix jacchus jacchus). (2001) (2)
- Oscillatory instability of body weight in alternating anorexia nervosa and bulimia nervosa (1992) (2)
- NEUROENDOCRINE RESPONSES TO LEVODOPA IN AFFECTIVE ILLNESS (1977) (2)
- Glucocorticoid Receptor (GR)‐Mediated Effects on Cocaine Kindling in Rats (1994) (2)
- Synthesis of doubly 13C-labelled antalarmin isotopomers for pharmacokinetic studies (2002) (2)
- Corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. (1987) (2)
- Miconazole: binding to the glucocorticoid receptor and effects on the primate pituitary-adrenal axis (1986) (2)
- 255. Body composition and regional fat content in patients with major depression (2000) (2)
- The impact of normal volunteers on a psychiatric research unit. (1979) (2)
- Injections of human corticotropin releasing factor (hCRF) – a rapidly metabolised peptide – cause elevations of plasma ACTH and cortisol that mimic endogenous secretory episodes in man (1985) (2)
- Antinuclear Antibodies and Antithyroid Antibodies in Psychiatric Patients (1987) (1)
- Introduction (1995) (1)
- 1003. Acute Ketamine Administration Corrects Abnormal Inflammatory Bone Markers in Major Depression (2017) (1)
- Intracerebroventricularly Transplanted Embryonic Neuronal Tissue from Inflammatory-Resistant F344/N Rats Decreases Acoustic Startle Responses in Inflammatory-Susceptible Lew/N Rats (1996) (1)
- Suppression of HPA axis response to stress in lactating women (1994) (1)
- Altered expression of type 2 CRH receptor mRNA in the VMH by glucocorticoids and starvation. (1998) (1)
- Oxytocin shows a diurnal rhythm in CSF of healthy volunteers (1994) (1)
- Pituitary-adrenal responses to oCRH and central neuropeptide levels in alcohol amnestic disorder (1991) (1)
- 232. Effects of acute and chronic social stress on levels of CSF corticotropin-releasing hormone (2000) (1)
- Mental health service barriers in rural U.S. Southern communities (2015) (0)
- Anxiolytic pretreatment modulates the pituitary and adrenal responses to insulin-induced hypoglycemia and to CRH in man (1987) (0)
- Forty years of neuroendocrinology: a tribute to SM McCann (1997) (0)
- Central and Peripheral Norepinephrine Secretion in Major Depression is Activated, as Assessed by 24 hour CSF and Plasma Sampling (2014) (0)
- Abnormal HPA axis function in S.A.D. normalized by bright light (1989) (0)
- Subject Index Vol. 50, 1989 (1989) (0)
- Corticotropin Releasing Factor (Hormone): Physiological and Clinical Implications (1989) (0)
- of day and menstrual cycle phase Hormonal and metabolic responses to exercise across time (2013) (0)
- Neuroimmunomodulation Editors Induction by Cytokines of the Pattern of Pituitary Hormone 2 Secretion in Infection Impairment of Adrenocortical Function Associated with 14 Increased Plasma Tumor Necrosis Factor-alpha and Interleu- Kin-6 Concentrations in African Trypanosomiasis Release of Immunoreact (0)
- THE DIURNAL RHYTHM IN CORTICOTROPIN RELEASING HORMONE IS INVERSELY RELATED TO THAT OF CORTISOL IN PRIMATE CEREBROSPINAL-FLUID (1987) (0)
- Neurohormonal Immune Phenotypes in Profiles : Presence of Lewis-and Fischer-Like Output Shapes Opposite Innate Cytokine Low-versus High-Baseline Epinephrine (2008) (0)
- Multiple FeedbackRegulatory LoopsuponRatHypothalamic Corticotropin-releasing HormoneSecretion (1988) (0)
- Subject Index Vol. 64, 1996 (1996) (0)
- Correction: Do Premenopausal Women with Major Depression Have Low Bone Mineral Density? A 36-Month Prospective Study (2012) (0)
- Dose-response effects of the anti-glucocorticoid steroid Ru486 upon ACTH, cortisol and arginine vasopressin secretion in primates (1985) (0)
- menitary-adrenal axis between groups of Marked differences in functioning of the (2015) (0)
- Methode de regulation neuro-endocrinienne permettant de traiter les troubles affectifs (1999) (0)
- Insulin-induced hypoglycemia in depression (1989) (0)
- In memoriam: Wylie Walker Vale, Jr (2012) (0)
- Subject Index Vol. 57, 1993 (1993) (0)
- MOLECULAR BIOLOGY OF STRESS Sponsored by: The Director's Sponsors Fund (1988) (0)
- NON-OPIATE PEPTIDES IN THE CEREBROSPINAL FLUID OF PATIENTS WITH NEUROPSYCHIATRIC DISORDERS (1984) (0)
- The brain and the immune system continuously signal each other, often along the same pathways, which may explain how state of mind influences health (2002) (0)
- Exercise renders human peripheral blood IL-6 production less sensitive to dexamethasone suppression (1994) (0)
- Stress System Dysregulation in Depression: From Molecular Biology to New Treatment Opportunities (2008) (0)
- Synthesis and Biological Activity of Fluoro‐Substituted Pyrrolo[2,3‐d]pyrimidines. The Development of Potential Positron Emission Tomography Imaging Agents for the Corticotropin‐Releasing Hormone Type 1 Receptor. (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Philip W. Gold?
Philip W. Gold is affiliated with the following schools:
